Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novamind Inc. NVMDF

Healthcare Biotechnology
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence... see more

Recent & Breaking News (OTCQB:NVMDF)

Novamind Launches Psychedelic Therapy Frontiers Podcast

Accesswire June 30, 2021

Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer

Accesswire June 23, 2021

Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company

Accesswire June 17, 2021

Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021

Accesswire June 15, 2021

Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers

Accesswire June 10, 2021

Novamind Reports Fiscal Q3 Financial Results and Operating Highlights

Accesswire June 1, 2021

Novamind Opens Client Care Center to Support High Demand for Treatments

Accesswire May 18, 2021

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

Accesswire May 4, 2021

Novamind Collaborates with Center for Change

Accesswire April 21, 2021

Novamind Announces Participation at the Planet MicroCap Showcase on April 20 - 22, 2021

Accesswire April 20, 2021

Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021

Accesswire April 19, 2021

Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

Accesswire April 19, 2021

Novamind Increases Strategic Investment in Bionomics

Accesswire April 13, 2021

Novamind to Present at Benzinga Biotech Conference

Newsfile March 24, 2021

Novamind to Present at Benzinga Biotech Conference

Accesswire March 22, 2021

IIROC Trade Resumption - NM

Canada NewsWire March 18, 2021

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Accesswire March 18, 2021

IIROC Trading Halt - NM

Canada NewsWire March 16, 2021

Novamind Expands Leadership Team, Accelerating M&A

Accesswire March 3, 2021

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Accesswire March 1, 2021